Prestige Consumer Healthcare Inc. (PBH) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Prestige Consumer Healthcare Inc. (PBH): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 57/100 — a percentile rank of Prestige Consumer Healthcare Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $2.2B |
| P / E | 12.6× |
| P / S | 2.0× |
| EV / EBITDA | 12.8× |
| Gross margin | 53.5% |
| Operating margin | 26.3% |
| Net margin | 15.6% |
| Return on equity | 9.0% |
| ROIC | 5.5% |
| Revenue growth | -1.4% |
| Debt / equity | 1.1× |
| Dividend yield | 0.0% |
Is Prestige Consumer Healthcare Inc. overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from Prestige Consumer Healthcare Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact